更新された供給不足状況を示しています。
ある時点での供給不足の全体的状況は「供給関連情報」に定期的にアップします。
米国
- 2024.10.29
- 2024.10.29
October 25, 2024
- Exenatide Synthetic Injection (Discontinuation)
October 24, 2024
- Amoxapine Tablet (Currently In Shortage)
October 22, 2024
- Atomoxetine Hydrochloride Capsule (Discontinuation)
- Telmisartan Tablet (Discontinuation)
October 21, 2024
- Technetium Tc-99m Sodium Pertechnetate Generator (Currently In Shortage)
- 2024.10.23
- 2024.10.23
October 18, 2024
- Duloxetine Hydrochloride Capsule, Delayed Release (Discontinuation)
October 16, 2024
- Oxaliplatin Injection (Discontinuation)
October 15, 2024
- Azithromycin For Suspension (Discontinuation)
- Candesartan Cilexetil Tablet (Discontinuation)
- Levalbuterol Hydrochloride Solution (Discontinuation)
- Silver Nitrate Solution (Discontinuation)
October 11, 2024
- Dextrose Monohydrate Injection (Currently In Shortage)
- Lactated Ringers Injection (Currently In Shortage)
- Linezolid Solution (Discontinuation)
- Oxaliplatin Injection (Discontinuation)
- Peritoneal Dialysis Solution (Currently In Shortage)
- 2024.10.10
一般名 欠品状況 改訂日 作成日 デシタビン注射液 現在の供給不足 2024年10月9日 2023年8月2日 ヘパリン注射液 現在の供給不足 2024年10月9日 2017年10月12日 酢酸ランレオチド注射液 現在の供給不足 2024年10月9日 2024年10月9日 マンニトール注射液 現在の供給不足 2024年10月9日 2024年10月9日 メフロキン塩酸塩錠 現在の供給不足 2024年10月9日 2024年10月9日 メトヘキシタール注｜医療機器 現在の供給不足 2024年10月9日 2024年9月17日 ナルブフィン 注射 現在の供給不足 2024年10月9日 2022年11月8日 注射用塩化カリウム大容量 現在の不足状況 2024年10月9日 2024年10月9日 アセチルシステイン経口・吸入液 現在の供給不足 2024年10月8日 2015年6月8日 デュラグルチド注射液 現在の供給不足 2024年10月8日 2022年8月19日 チルゼパチド注射液 現在の供給不足 2024年10月8日 2023年7月20日 トポテカン注 解消された供給不足 2024年10月8日 2024年2月5日 トラマドール錠 現在の供給不足 2024年10月8日 2020年1月21日 0.45%塩化ナトリウム注射用バッグ 現在の供給不足 2024年10月7日 2024年10月7日 アルブテロール硫酸塩およびイプラトロピウム臭化物吸入液 現在の供給不足 2024年10月7日 2023年1月9日 アンブリセンタン錠 現在の供給不足 2024年10月7日 2024年5月7日 カペシタビン錠 現在の供給不足 2024年10月7日 2023年2月1日 ドクセルカルシフェロールカプセル 解消された欠品 2024年10月7日 2020年10月29日 モメタゾンフロエート経口吸入剤 解消された供給不足 2024年10月7日 2024年1月18日 アシクロビル注射液 現在の供給不足 2024年10月6日 2024年2月21日 ブデソニド吸入用懸濁液 現在の供給不足 2024年10月6日 2023年5月30日 塩酸コカイン4%点鼻液 解消された欠品 2024年10月6日 2024年1月17日 乳酸リンゲル注射液 現在の供給不足 2024年10月6日 2024年 10月 06日 乳酸リンゲル液 現在の供給不足 2024年10月6日 2024年10月6日 硫酸マグネシウム注射液 現在の供給不足 2024年10月6日 2015年5月29日 ナイスタチン経口懸濁液 現在の供給不足 2024年10月6日 2024年6月21日 オキシコドン塩酸塩即時放出錠 現在の供給不足 2024年10月6日 2023年3月16日 リン酸カリウム注射液 現在の供給不足 2024年10月6日 2021年9月1日 レミフェンタニル 注射 現在の供給不足 2024年10月6日 2022年6月22日 セマグルチド 注射 現在の供給不足 2024年10月6日 2022年3月11日 酢酸ナトリウム注射液 現在の供給不足 2024年10月6日 2021年9月1日 炭酸水素ナトリウム注射液 現在の供給不足 2024年10月6日 2017年2月17日 リン酸ナトリウム注射液 解消された供給不足 2024年10月6日 2021年8月23日 スルファサラジン腸溶錠および即時放出錠 現在の供給不足 2024年10月6日 2020年1月8日 硫酸ビンブラスチン注射液 現在の供給不足 2024年10月6日 2023年9月1日 0.9%塩化ナトリウム灌漑 現在の不足 2024年10月4日 2022年2月25日 0.9%塩化ナトリウム大容量袋 現在の不足状況 2024年10月4日 2024年10月4日 10%ブドウ糖注射液 現在の供給不足 2024年10月4日 2024年10月4日 5%ブドウ糖注射液 (PVCおよびDEHPフリー) 現在の供給不足 2024年10月4日 2024年10月4日 5%ブドウ糖注射液大容量バッグ 現在の供給不足 2024年10月4日 2024年10月4日 5%ブドウ糖注射液小容量バッグ 現在の欠品状況 2024年10月4日 2022年2月4日 70%ブドウ糖注射液大容量バッグ 現在の供給不足 2024年10月4日 2022年7月13日 注射用滅菌水 – 大容量バッグ 現在の不足状況 2024年10月4日 2024年 10月 04日 灌漑用無菌水 現在の不足 2024年10月4日 2023年5月3日 ジシクロミン口頭発表 現在の供給不足 2024年10月3日 2019年1月22日 ヒドロキソコバラミン筋注液 解消された欠品 2024年10月3日 2023年9月8日 セフォタキシムナトリウム注射液 現在の供給不足 2024年10月2日 2015年6月10日 コラゲナーゼ軟膏 解消された欠品 2024年10月2日 2023年8月23日 ダントロレンナトリウム注射液 現在の供給不足 2024年10月2日 2024年6月5日 リチウム内用液 現在の不足状況 2024年10月2日 2020年4月27日 トリアムシノロンアセトニド硝子体内注射液 現在の供給不足 2024年10月2日 2021年9月30日 オセルタミビル経口懸濁液・カプセル 現在の供給不足 2024年10月1日 2022年11月1日 アカンプロサートカルシウム錠 現在の供給不足 2024年9月30日 2024年9月30日 アザチオプリンナトリウム注射液 現在の供給不足 2024年9月30日 2024年9月30日 デキサメタゾンリン酸エステルナトリウム注射液 現在の供給不足 2024年9月29日 2015年 08月 06日 ジフェンヒドラミン注射液 現在の供給不足 2024年9月29日 2022年3月14日 ドブタミン注射液 現在の供給不足 2024年9月29日 2017年 03月 01日 ドパミン塩酸塩注射液 現在の供給不足 2024年9月29日 2022年3月9日 エストラジオールサイピオン酸塩注射液 現在の供給不足 2024年9月29日 2024年7月9日 イソニアジド錠 現在の供給不足 2024年9月29日 2022年9月1日 - 2024.10.10
October 3, 2024
- Fluoxetine Hydrochloride Capsule (Discontinuation)
September 30, 2024
- Irinotecan Hydrochloride Injection (Discontinuation
カナダ
カナダの情報はありません。
オーストラリア
- 2024.10.29
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated gabapentin Capsule, hard 300 mg Current Limited Availability Manufacturing 25/10/2024 sumatriptan succinate Tablet, film coated 140 mg Current Limited Availability Manufacturing 25/10/2024 azithromycin dihydrate Tablet, film coated 524.1 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 25/10/2024 dutasteride~tamsulosin hydrochloride Capsule, modified release 500 microgram~400 microgram Current Limited Availability Manufacturing 25/10/2024 valsartan~hydrochlorothiazide Tablet, film coated 320 mg~25 mg Current Limited Availability Manufacturing 25/10/2024 esomeprazole magnesium dihydrate Tablet, enteric coated 21.75 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 25/10/2024 clonidine hydrochloride Tablet 100 microgram Anticipated Available Manufacturing 25/10/2024 fluorouracil Injection, solution 50 mg/mL Resolved Available Manufacturing 25/10/2024 verapamil hydrochloride Tablet, modified release 180 mg Current Limited Availability Manufacturing 25/10/2024 estradiol hemihydrate Drug delivery system, transdermal 1.54 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 25/10/2024 estradiol hemihydrate Drug delivery system, transdermal .77 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 25/10/2024 oxycodone hydrochloride Capsule, hard 5 mg Resolved Available Manufacturing 25/10/2024 nizatidine Capsule 300 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 25/10/2024 flecainide acetate Injection, solution 10 mg/mL Anticipated Available Manufacturing 24/10/2024 topiramate Tablet, film coated 200 mg Anticipated Available Manufacturing 24/10/2024 gliclazide Tablet, modified release 30 mg Resolved Available Manufacturing 24/10/2024 donepezil hydrochloride Tablet, film coated 5 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 24/10/2024 bisoprolol fumarate Tablet 5 mg Current Unavailable Manufacturing 24/10/2024 bicalutamide Tablet, film coated 50 mg Anticipated Available Manufacturing 24/10/2024 azithromycin dihydrate Tablet, film coated 524.05 mg Current Limited Availability Manufacturing 24/10/2024 duloxetine hydrochloride Capsule, enteric 67.3 mg Current Limited Availability Manufacturing 24/10/2024 quetiapine fumarate Tablet, film coated 28.78 mg Anticipated Available Manufacturing 24/10/2024 rizatriptan benzoate Tablet, orally disintegrating 14.53 mg Resolved Available Transport / Logistic issues / Storage capacity issues 24/10/2024 simvastatin Tablet, film coated 40 mg Current Unavailable Manufacturing 24/10/2024 citalopram hydrobromide Tablet, film coated 49.98 mg Current Unavailable Manufacturing 24/10/2024 citalopram hydrobromide Tablet, film coated 49.98 mg Anticipated Available Manufacturing 24/10/2024 mitomycin Injection, powder for 20 mg Resolved Available Manufacturing 24/10/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 24/10/2024 emtricitabine~tenofovir disoproxil maleate Tablet, film coated 200 mg~300 mg Current Unavailable Manufacturing 24/10/2024 prochlorperazine maleate Tablet, uncoated 5 mg Current Unavailable Commercial Changes / Commercial viability 24/10/2024 nebivolol hydrochloride Tablet 1.363 mg Current Unavailable Manufacturing 24/10/2024 betahistine dihydrochloride Tablet, uncoated 16 mg Current Limited Availability Manufacturing 24/10/2024 cinacalcet hydrochloride Tablet 99.191 mg Current Limited Availability Manufacturing 24/10/2024 dosulepin (dothiepin) hydrochloride Capsule, hard 25 mg Current Unavailable Manufacturing 24/10/2024 azacitidine Injection, powder for 100 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 24/10/2024 estradiol Drug delivery system, transdermal 1.56 mg Current Limited Availability Manufacturing 24/10/2024 flecainide acetate Tablet 50 mg Current Unavailable Manufacturing 24/10/2024 bortezomib Injection, solution 3.5 mg Current Unavailable Manufacturing 24/10/2024 paracetamol Tablet, modified release 665 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 24/10/2024 norethisterone acetate~estradiol Drug delivery system, transdermal 4.8 mg~.512 mg Current Limited Availability Manufacturing 24/10/2024 metformin hydrochloride Tablet, film coated 850 mg Current Unavailable Manufacturing 24/10/2024 pravastatin sodium Tablet, uncoated 40 mg Current Limited Availability Manufacturing 24/10/2024 medronic acid Injection, powder for 10 mg Current Limited Availability Manufacturing 23/10/2024 donepezil hydrochloride Tablet, film coated 10 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 23/10/2024 levetiracetam Tablet, film coated 250 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 23/10/2024 bisoprolol fumarate Tablet 2.5 mg Current Unavailable Manufacturing 23/10/2024 bisoprolol fumarate Tablet 10 mg Anticipated Available Manufacturing 23/10/2024 irbesartan Tablet, film coated 300 mg Resolved Available Manufacturing 23/10/2024 methotrexate Injection, solution 100 mg/mL Current Unavailable Manufacturing 23/10/2024 epirubicin hydrochloride Injection, concentrated 200 mg Current Unavailable Manufacturing 23/10/2024 betahistine dihydrochloride Tablet 24 mg Current Limited Availability Unexpected increase in consumer demand 23/10/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Manufacturing 23/10/2024 tenofovir disoproxil fumarate~emtricitabine Tablet, film coated 300 mg~200 mg Current Unavailable Manufacturing 23/10/2024 tadalafil Tablet, film coated 10 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 23/10/2024 lacosamide Tablet, film coated 50 mg Anticipated Available Manufacturing 23/10/2024 lidocaine hydrochloride Injection, solution 400 mg Current Unavailable Manufacturing 23/10/2024 amlodipine besilate~olmesartan medoxomil~hydrochlorothiazide Tablet, film coated 6.95 mg~40 mg~25 mg Current Unavailable Manufacturing 23/10/2024 amoxicillin trihydrate Oral Liquid, powder for 114.82 mg/mL Resolved Available Manufacturing 23/10/2024 cytarabine Injection, solution 100 mg Current Limited Availability Unexpected increase in consumer demand 22/10/2024 papaverine hydrochloride Injection, solution 12 mg/mL Current Limited Availability Manufacturing 22/10/2024 clonidine hydrochloride Tablet, uncoated 100 microgram Resolved Available Manufacturing 22/10/2024 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~5.198 mg Resolved Available Manufacturing 22/10/2024 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~20.791 mg Current Limited Availability Manufacturing 22/10/2024 levetiracetam Injection, concentrated 500 mg Resolved Available Manufacturing 22/10/2024 pemetrexed disodium Injection, powder for 1102.9 mg Current Unavailable Manufacturing 22/10/2024 meloxicam Capsule, hard 15 mg Anticipated Available Manufacturing 22/10/2024 cisplatin Injection, concentrated 1 mg/mL Current Unavailable Unexpected increase in consumer demand 22/10/2024 rasagiline mesilate Tablet 1.56 mg Current Limited Availability Manufacturing 22/10/2024 celecoxib Capsule, hard 100 mg Resolved Available Manufacturing 22/10/2024 solifenacin succinate Tablet, film coated 5 mg Current Unavailable Manufacturing 22/10/2024 solifenacin succinate Tablet, film coated 10 mg Current Unavailable Manufacturing 22/10/2024 lacosamide Tablet, film coated 100 mg Resolved Available Manufacturing 22/10/2024 modafinil Tablet, uncoated 100 mg Resolved Available Manufacturing 22/10/2024 quinagolide hydrochloride Tablet, uncoated .0819 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 22/10/2024 clarithromycin Oral Liquid, powder for 50 mg/mL Current Limited Availability Unexpected increase in consumer demand 22/10/2024 norethisterone~ethinylestradiol Tablet, uncoated 1 mg~36 microgram Current Limited Availability Manufacturing 22/10/2024 clonidine hydrochloride Tablet, uncoated 150 microgram Resolved Available Manufacturing 22/10/2024 methylphenidate hydrochloride Tablet, modified release 54 mg Current Limited Availability Manufacturing 22/10/2024 adrenaline (epinephrine) acid tartrate Injection, solution 1.82 mg/mL Anticipated Available Manufacturing 21/10/2024 topiramate Tablet, film coated 25 mg Anticipated Available Manufacturing 21/10/2024 pentetic acid Injection, powder for 5 mg Current Limited Availability Manufacturing 21/10/2024 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~10.396 mg Current Limited Availability Manufacturing 21/10/2024 rosuvastatin calcium~ezetimibe Tablet~Tablet, film coated 20.791 mg~10 mg Current Limited Availability Manufacturing 21/10/2024 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~5.198 mg Current Limited Availability Manufacturing 21/10/2024 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~10.396 mg Resolved Available Manufacturing 21/10/2024 paclitaxel Injection, concentrated 300 mg Resolved Available Manufacturing 21/10/2024 milrinone Injection, concentrated 10 mg Resolved Available Manufacturing 21/10/2024 cefepime hydrochloride monohydrate Injection, powder for 1189.2 mg Current Limited Availability Manufacturing 21/10/2024 temozolomide Capsule, hard 20 mg Anticipated Available Manufacturing 21/10/2024 benzatropine mesilate Injection 1 mg/mL Anticipated Available Manufacturing 21/10/2024 hydromorphone hydrochloride Injection, solution 2 mg Current Limited Availability Manufacturing 21/10/2024 atorvastatin calcium trihydrate Tablet, film coated 86.751 mg Anticipated Available Manufacturing 21/10/2024 lenalidomide Capsule, hard 5 mg Resolved Available Unexpected increase in consumer demand 21/10/2024 levothyroxine sodium Tablet 50 microgram Current Unavailable Manufacturing 21/10/2024 clindamycin hydrochloride Solution 10 mg/mL Current Unavailable Manufacturing 21/10/2024 sodium pertechnetate(99mTc) Injection, solution 20 GBq Resolved Available Manufacturing 21/10/2024 balsalazide sodium Capsule 750 mg Resolved Available Commercial Changes / Commercial viability 21/10/2024 - 2024.10.23
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated sumatriptan succinate Tablet, film coated 140 mg Current Limited Availability Manufacturing 18/10/2024 topiramate Tablet, film coated 50 mg Anticipated Available Manufacturing 18/10/2024 topiramate Tablet, film coated 100 mg Anticipated Available Manufacturing 18/10/2024 heparin sodium Injection, solution 5000 IU/mL Anticipated Available Unexpected increase in consumer demand 18/10/2024 tamsulosin hydrochloride~dutasteride Capsule, modified release 400 microgram~500 microgram Current Limited Availability Manufacturing 18/10/2024 metformin hydrochloride Tablet, modified release 1000 mg Current Limited Availability Manufacturing 18/10/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 18/10/2024 oxycodone hydrochloride Capsule, hard 10 mg Current Unavailable Commercial Changes / Commercial viability 18/10/2024 fenofibrate Tablet 48 mg Resolved Available Manufacturing 18/10/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 18/10/2024 latanoprost Eye Drops, solution .05 mg/mL Resolved Available Transport / Logistic issues / Storage capacity issues 18/10/2024 lacosamide Tablet, film coated 150 mg Current Unavailable Manufacturing 18/10/2024 pregabalin Capsule, hard 75 mg Resolved Available Manufacturing 18/10/2024 pregabalin Capsule, hard 75 mg Resolved Available Manufacturing 18/10/2024 atorvastatin calcium trihydrate Tablet, film coated 86.751 mg Current Limited Availability Manufacturing 18/10/2024 trimethoprim Tablet, uncoated 300 mg Current Limited Availability Manufacturing 18/10/2024 dosulepin (dothiepin) hydrochloride Capsule, hard 25 mg Current Unavailable Manufacturing 18/10/2024 indometacin Capsule, hard 25 mg Current Unavailable Manufacturing 18/10/2024 octreotide Injection, solution 50 microgram/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 18/10/2024 clonazepam Tablet, uncoated .5 mg Current Limited Availability Manufacturing 18/10/2024 clonazepam Tablet, uncoated 2 mg Current Limited Availability Manufacturing 18/10/2024 estradiol hemihydrate Drug delivery system, transdermal 1.54 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 18/10/2024 tobramycin Inhalation, conventional 60 mg/mL Current Unavailable Manufacturing 18/10/2024 topiramate Tablet, film coated 200 mg Anticipated Available Manufacturing 17/10/2024 adrenaline (epinephrine) Injection, solution 1 mg Resolved Available Manufacturing 17/10/2024 mitomycin Injection, powder for 20 mg Current Unavailable Manufacturing 17/10/2024 azacitidine Injection, powder for 100 mg Current Unavailable Manufacturing 17/10/2024 irbesartan Tablet, film coated 150 mg Resolved Available Manufacturing 17/10/2024 tadalafil Tablet, film coated 5 mg Current Unavailable Manufacturing 17/10/2024 lisdexamfetamine dimesilate Capsule, hard 60 mg Resolved Available Unexpected increase in consumer demand 17/10/2024 letrozole Tablet, film coated 2.5 mg Current Limited Availability Manufacturing 17/10/2024 nebivolol hydrochloride Tablet 5.45 mg Current Limited Availability Manufacturing 17/10/2024 daptomycin Injection, powder for 500 mg Current Unavailable Commercial Changes / Commercial viability 17/10/2024 tamoxifen citrate Tablet 30.34 mg Current Limited Availability Manufacturing 17/10/2024 olanzapine pamoate monohydrate Injection, powder for 931 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 16/10/2024 risperidone Tablet, film coated 4 mg Anticipated Available Manufacturing 16/10/2024 rocuronium bromide Injection, solution 50 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 16/10/2024 adrenaline (epinephrine) Injection, solution 1 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 16/10/2024 atorvastatin calcium trihydrate~ezetimibe Tablet, multilayer 10.9 mg~10 mg Resolved Available Manufacturing 16/10/2024 entecavir Tablet, film coated 1 mg Resolved Available Manufacturing 16/10/2024 hydrochlorothiazide~irbesartan Tablet, film coated 25 mg~300 mg Anticipated Available Manufacturing 16/10/2024 tadalafil Tablet, film coated 10 mg Anticipated Available Manufacturing 16/10/2024 tadalafil Tablet, film coated 5 mg Resolved Available Manufacturing 16/10/2024 cisplatin Injection, concentrated 1 mg/mL Anticipated Available Manufacturing 16/10/2024 linezolid Tablet, film coated 600 mg Resolved Available Unexpected increase in consumer demand 16/10/2024 latanoprost~timolol maleate Eye Drops, solution .05 mg/mL~6.83 mg/mL Anticipated Available Manufacturing 16/10/2024 dutasteride~tamsulosin hydrochloride Capsule, modified release 500 microgram~400 microgram Anticipated Available Transport / Logistic issues / Storage capacity issues 16/10/2024 bendamustine hydrochloride monohydrate Injection, powder for 100 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 16/10/2024 amlodipine besilate~olmesartan medoxomil Tablet, film coated 6.94 mg~40 mg Current Unavailable Unexpected increase in consumer demand 16/10/2024 methylphenidate hydrochloride Tablet, modified release 27 mg Resolved Available Manufacturing 16/10/2024 daptomycin Inhalation, powder for 350 mg Anticipated Available Manufacturing 16/10/2024 enoxaparin sodium Injection, solution 20 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 16/10/2024 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~41.6 mg Current Unavailable Manufacturing 16/10/2024 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~20.8 mg Resolved Available Manufacturing 16/10/2024 nizatidine Capsule, hard 300 mg Resolved Available Manufacturing 16/10/2024 Tenecteplase Injection, powder for 50 mg Resolved Available Unexpected increase in consumer demand 16/10/2024 sodium pertechnetate(99mTc) Injection 370 GBq Resolved Available Manufacturing 16/10/2024 ciprofloxacin hydrochloride Tablet, film coated 873.32 mg Anticipated Available Manufacturing 16/10/2024 nizatidine Capsule 150 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 16/10/2024 nizatidine Capsule, hard 300 mg Resolved Available Manufacturing 16/10/2024 acetylcholine chloride Solution, powder for irrigation 10 mg/mL Current Unavailable Manufacturing 15/10/2024 daunorubicin Injection, solution 20 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 15/10/2024 anidulafungin Injection, powder for 100 mg Current Limited Availability Manufacturing 15/10/2024 mycophenolate mofetil Tablet, film coated 500 mg Current Limited Availability Manufacturing 15/10/2024 duloxetine hydrochloride Capsule, enteric 67.3 mg Current Limited Availability Manufacturing 15/10/2024 Digoxinspecific antibody fragment F(ab) (Ovine) Injection, powder for 40 mg Anticipated Available Manufacturing 15/10/2024 duloxetine hydrochloride Capsule, enteric 33.66 mg Current Unavailable Unexpected increase in consumer demand 15/10/2024 escitalopram oxalate Tablet, film coated 12.74 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 15/10/2024 escitalopram oxalate Tablet, film coated 25.47 mg Current Unavailable Manufacturing 15/10/2024 rizatriptan benzoate Tablet, orally disintegrating 14.53 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 15/10/2024 Follitropin alfa Injection, solution 75 IU Current Limited Availability Manufacturing 15/10/2024 atorvastatin calcium trihydrate Tablet, film coated 86.76 mg Resolved Available Manufacturing 15/10/2024 cinacalcet hydrochloride Tablet 99.191 mg Current Limited Availability Manufacturing 15/10/2024 tadalafil Tablet, film coated 5 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 15/10/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Unexpected increase in consumer demand 15/10/2024 dosulepin (dothiepin) hydrochloride Capsule, hard 25 mg Current Unavailable Manufacturing 15/10/2024 prasugrel Tablet, film coated 5 mg Current Unavailable Manufacturing 15/10/2024 prasugrel Tablet, film coated 10 mg Current Limited Availability Manufacturing 15/10/2024 estradiol Drug delivery system, transdermal .585 mg Current Unavailable Manufacturing 15/10/2024 estradiol Drug delivery system, transdermal 1.17 mg Current Unavailable Manufacturing 15/10/2024 flecainide acetate Tablet 50 mg Current Unavailable Manufacturing 15/10/2024 pegcetacoplan Injection, solution 1080 mg Resolved Available Manufacturing 15/10/2024 rocuronium bromide Injection, solution 10 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 15/10/2024 estradiol~norethisterone acetate Drug delivery system, transdermal .62 mg~2.7 mg Resolved Available Manufacturing 15/10/2024 pimecrolimus Cream 10 mg/g Resolved Available Manufacturing 15/10/2024 clarithromycin Tablet, film coated 250 mg Anticipated Available Unexpected increase in consumer demand 15/10/2024 griseofulvin Tablet, uncoated 125 mg Resolved Available Manufacturing 14/10/2024 olsalazine sodium Capsule 250 mg Current Unavailable Manufacturing 14/10/2024 iopromide Injection, solution 498.72 mg/mL Current Unavailable Unexpected increase in consumer demand 14/10/2024 telmisartan~hydrochlorothiazide Tablet, film coated 80 mg~12.5 mg Current Limited Availability Manufacturing 14/10/2024 esomeprazole magnesium dihydrate Tablet, enteric coated 21.75 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 14/10/2024 benzathine benzylpenicillin tetrahydrate Injection, suspension 600000 USP Unit Current Unavailable Manufacturing 14/10/2024 oseltamivir phosphate Capsule, hard 98.524 mg Anticipated Available Unexpected increase in consumer demand 14/10/2024 thiotepa Injection, powder for 15 mg Anticipated Available Commercial Changes / Commercial viability 14/10/2024 betahistine dihydrochloride Tablet 16 mg Resolved Available Unexpected increase in consumer demand 14/10/2024 cisplatin Injection, solution 1 mg/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 14/10/2024 olsalazine sodium Tablet, uncoated 500 mg Current Unavailable Manufacturing 14/10/2024 clarithromycin Tablet, film coated 250 mg Current Limited Availability Manufacturing 11/10/2024 primidone Tablet, uncoated 250 mg Current Limited Availability Manufacturing 11/10/2024 neostigmine methylsulfate Injection, solution 2.5 mg Anticipated Available Manufacturing 11/10/2024 tadalafil Tablet 5 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 11/10/2024 tadalafil Tablet, film coated 5 mg Resolved Available Manufacturing 11/10/2024 heparin sodium Injection, solution 5000 IU/mL Current Limited Availability Manufacturing 11/10/2024 midazolam Injection, solution 5 mg/mL Resolved Available Manufacturing 11/10/2024 metoprolol succinate Tablet, modified release 190 mg Anticipated Available Manufacturing 10/10/2024 bisoprolol fumarate Tablet 5 mg Current Unavailable Manufacturing 10/10/2024 nebivolol hydrochloride Tablet 1.363 mg Anticipated Available Manufacturing 10/10/2024 - 2024.10.10
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated atropine sulfate monohydrate Injection, solution 1.2 mg/mL Resolved Available Manufacturing 9/10/2024 acetylcysteine Injection, concentrated 2 g Anticipated Available Manufacturing 9/10/2024 trandolapril Capsule 2 mg Resolved Available Transport / Logistic issues / Storage capacity issues 9/10/2024 isosorbide dinitrate Tablet, uncoated 5 mg Current Limited Availability Manufacturing 9/10/2024 morphine hydrochloride trihydrate Oral Liquid, solution 1 mg/mL Resolved Available Commercial Changes / Commercial viability 9/10/2024 risperidone Tablet, film coated 1 mg Current Unavailable Manufacturing 9/10/2024 acetylcysteine Injection, concentrated 2 g Current Limited Availability Transport / Logistic issues / Storage capacity issues 9/10/2024 galantamine hydrobromide Capsule, modified release 30.756 mg Anticipated Available Manufacturing 9/10/2024 adrenaline (epinephrine) acid tartrate Injection, solution 182 microgram/mL Current Unavailable Manufacturing 9/10/2024 citalopram hydrobromide Tablet, film coated 49.98 mg Anticipated Available Manufacturing 9/10/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Manufacturing 9/10/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 9/10/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 9/10/2024 adrenaline (epinephrine) acid tartrate Injection, solution 1.819 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 9/10/2024 metformin hydrochloride Tablet, film coated 850 mg Resolved Available Manufacturing 9/10/2024 lacosamide Tablet, film coated 100 mg Resolved Available Manufacturing 9/10/2024 codeine phosphate hemihydrate~doxylamine succinate~paracetamol Tablet, uncoated 30 mg~5 mg~450 mg Resolved Available Manufacturing 9/10/2024 amlodipine besilate~hydrochlorothiazide~olmesartan medoxomil Tablet, film coated 6.95 mg~12.5 mg~40 mg Current Unavailable Manufacturing 9/10/2024 calcium chloride dihydrate~magnesium chloride hexahydrate~sodium lactate~glucose~sodium chloride Solution, irrigation 183 mg/L~50.8 mg/L~4.48 g/L~15 g/L~5.38 g/L Current Limited Availability Manufacturing 8/10/2024 calcium chloride dihydrate~glucose~sodium lactate~magnesium chloride hexahydrate~sodium chloride Solution, irrigation 183 mg/L~25 g/L~4.48 g/L~50.8 mg/L~5.38 g/L Current Limited Availability Manufacturing 8/10/2024 levetiracetam Tablet, film coated 500 mg Resolved Available Transport / Logistic issues / Storage capacity issues 8/10/2024 codeine phosphate hemihydrate~doxylamine succinate~paracetamol Tablet, uncoated 10 mg~5.1 mg~500 mg Current Unavailable Manufacturing 8/10/2024 paclitaxel Injection, concentrated 300 mg Current Unavailable Manufacturing 8/10/2024 milrinone Injection, concentrated 10 mg Current Limited Availability Manufacturing 8/10/2024 azithromycin dihydrate Tablet, film coated 524 mg Current Unavailable Manufacturing 8/10/2024 cisplatin Injection, concentrated 1 mg/mL Anticipated Available Manufacturing 8/10/2024 lacosamide Tablet, film coated 150 mg Current Unavailable Manufacturing 8/10/2024 gliclazide Tablet, uncoated 80 mg Resolved Available Unexpected increase in consumer demand 8/10/2024 ketorolac trometamol Injection, solution 30 mg/mL Resolved Available Manufacturing 8/10/2024 phentermine hydrochloride Tablet, modified release 49.7 mg Current Limited Availability Manufacturing 8/10/2024 carmustine Injection, powder for 100 mg Current Unavailable Manufacturing 8/10/2024 methotrexate Tablet 10 mg Current Limited Availability Manufacturing 8/10/2024 sitagliptin hydrochloride monohydrate Tablet, film coated 109 mg Current Unavailable Manufacturing 8/10/2024 sitagliptin hydrochloride monohydrate Tablet, film coated 54.5 mg Current Unavailable Manufacturing 8/10/2024 sitagliptin hydrochloride monohydrate Tablet, film coated 27.25 mg Current Unavailable Manufacturing 8/10/2024 Adalimumab Injection, solution 40 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 8/10/2024 levothyroxine sodium Tablet, uncoated .05 mg Current Unavailable Manufacturing 8/10/2024 cisplatin Injection, solution 1 mg/mL Resolved Available Unexpected increase in consumer demand 8/10/2024 verapamil hydrochloride Tablet, modified release 180 mg Current Limited Availability Manufacturing 8/10/2024 rifabutin Capsule, hard 150 mg Resolved Available Manufacturing 8/10/2024 rizatriptan benzoate Wafer 14.53 mg Resolved Available Manufacturing 8/10/2024 pamidronate disodium Injection, concentrated 6 mg Current Limited Availability Manufacturing 8/10/2024 doxorubicin hydrochloride Injection, concentrated 2 mg/mL Resolved Available Manufacturing 8/10/2024 pegcetacoplan Injection, solution 1080 mg Anticipated Available Manufacturing 7/10/2024 duloxetine hydrochloride Capsule, enteric 33.7 mg Discontinued Unavailable Commercial Changes / Commercial viability 4/10/2024 duloxetine hydrochloride Capsule, enteric 67.3 mg Discontinued Unavailable Commercial Changes / Commercial viability 4/10/2024 medronic acid Injection, powder for 10 mg Anticipated Available Manufacturing 4/10/2024 fluoxetine hydrochloride Capsule, hard 22.36 mg Discontinued Unavailable Commercial Changes / Commercial viability 4/10/2024 Liraglutide Injection, solution 6 mg/mL Discontinued Unavailable Commercial Changes / Commercial viability 4/10/2024 adrenaline (epinephrine) Injection, solution 1 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 4/10/2024 Choriogonadotropin alfa Injection, solution 250 microgram Current Emergency Supply Only Unexpected increase in consumer demand 4/10/2024 noradrenaline (norepinephrine) acid tartrate monohydrate Injection, concentrated 8 mg Current Limited Availability Manufacturing 4/10/2024 topotecan hydrochloride Injection, concentrated 4.346 mg Current Unavailable Manufacturing 4/10/2024 Rabies virus Powder 3.25 IU Resolved Available Unexpected increase in demand due to other sponsors unable to supply 4/10/2024 sumatriptan succinate Tablet, film coated 140 mg Current Limited Availability Manufacturing 3/10/2024 midazolam Injection, solution 5 mg Current Limited Availability Manufacturing 3/10/2024 tamsulosin hydrochloride~dutasteride Capsule, modified release 400 microgram~500 microgram Current Limited Availability Manufacturing 3/10/2024 clonidine hydrochloride Tablet, uncoated 100 microgram Current Limited Availability Manufacturing 3/10/2024 duloxetine hydrochloride Capsule, enteric 33.65 mg Current Unavailable Manufacturing 3/10/2024 duloxetine hydrochloride Capsule, enteric 67.3 mg Current Unavailable Manufacturing 3/10/2024 telmisartan~hydrochlorothiazide Tablet, film coated 80 mg~12.5 mg Current Limited Availability Manufacturing 3/10/2024 quetiapine fumarate Tablet, film coated 28.78 mg Current Limited Availability Manufacturing 3/10/2024 metformin hydrochloride Tablet, modified release 1000 mg Current Limited Availability Manufacturing 3/10/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 3/10/2024 betahistine dihydrochloride Tablet 16 mg Resolved Available Manufacturing 3/10/2024 potassium clavulanate~amoxicillin trihydrate Tablet, film coated 148.875 mg~1006.25 mg Resolved Available Manufacturing 3/10/2024 clonidine hydrochloride Tablet 100 microgram Resolved Available Unexpected increase in consumer demand 3/10/2024 tenofovir disoproxil fumarate~emtricitabine Tablet, film coated 300 mg~200 mg Current Unavailable Manufacturing 3/10/2024 cinacalcet hydrochloride Tablet 99.191 mg Current Limited Availability Manufacturing 3/10/2024 celecoxib Capsule, hard 100 mg Current Limited Availability Manufacturing 3/10/2024 apomorphine hydrochloride hemihydrate Injection, solution 10 mg Current Limited Availability Manufacturing 3/10/2024 lacosamide Tablet, film coated 100 mg Current Unavailable Manufacturing 3/10/2024 eftrenonacog alfa Injection, powder for 4000 IU Resolved Available Manufacturing 3/10/2024 atorvastatin calcium trihydrate Tablet, film coated 86.751 mg Anticipated Available Manufacturing 3/10/2024 trimethoprim Tablet, uncoated 300 mg Anticipated Available Manufacturing 3/10/2024 dosulepin (dothiepin) hydrochloride Capsule, hard 25 mg Current Unavailable Manufacturing 3/10/2024 indometacin Capsule, hard 25 mg Current Unavailable Manufacturing 3/10/2024 mycophenolate mofetil Suspension 200 mg/mL Resolved Available Manufacturing 3/10/2024 levothyroxine sodium Tablet, uncoated .075 mg Current Unavailable Manufacturing 3/10/2024 levothyroxine sodium Tablet, uncoated .2 mg Current Unavailable Manufacturing 3/10/2024 estradiol hemihydrate Drug delivery system, transdermal 1.54 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 3/10/2024 imipramine hydrochloride Tablet, sugar coated 25 mg Current Unavailable Manufacturing 3/10/2024 estradiol hemihydrate Drug delivery system, transdermal .77 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 3/10/2024 estradiol hemihydrate Drug delivery system, transdermal 3.09 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 3/10/2024 celecoxib Capsule, hard 100 mg Resolved Available Manufacturing 3/10/2024 norethisterone acetate~estradiol Drug delivery system, transdermal 2.7 mg~.62 mg Current Unavailable Manufacturing 3/10/2024 amoxicillin trihydrate Tablet, film coated 1148 mg Resolved Available Manufacturing 3/10/2024 ciprofloxacin hydrochloride Tablet, film coated 873.32 mg Anticipated Available Manufacturing 3/10/2024 nizatidine Capsule 150 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 3/10/2024 lisinopril dihydrate Tablet, uncoated 10.89 mg Resolved Available Manufacturing 2/10/2024 escitalopram oxalate Tablet, film coated 25.56 mg Resolved Available Manufacturing 2/10/2024 topiramate Tablet, film coated 200 mg Anticipated Available Manufacturing 2/10/2024 zolpidem tartrate Tablet, film coated 10 mg Anticipated Available Manufacturing 2/10/2024 isoniazid Tablet, uncoated 100 mg Resolved Available Manufacturing 2/10/2024 ciprofloxacin hydrochloride Tablet, film coated 832.5 mg Anticipated Available Manufacturing 2/10/2024 gliclazide Tablet, modified release 30 mg Anticipated Available Manufacturing 2/10/2024 silver sulfadiazine Cream 10 mg/g Current Unavailable Manufacturing 2/10/2024 silver sulfadiazine Cream 10 mg/g Current Limited Availability Manufacturing 2/10/2024 risperidone Tablet, film coated 4 mg Anticipated Available Manufacturing 2/10/2024 donepezil hydrochloride Tablet, film coated 5 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 2/10/2024 hydrocortisone sodium succinate Injection, powder for 334.25 mg Current Limited Availability Manufacturing 2/10/2024 bicalutamide Tablet, film coated 50 mg Anticipated Available Manufacturing 2/10/2024 quetiapine fumarate Tablet, film coated 115.12 mg Resolved Available Manufacturing 2/10/2024 quetiapine fumarate Tablet, film coated 345.36 mg Current Limited Availability Manufacturing 2/10/2024 simvastatin Tablet, film coated 80 mg Anticipated Available Manufacturing 2/10/2024 citalopram hydrobromide Tablet, film coated 49.98 mg Anticipated Available Manufacturing 2/10/2024 fluorouracil Injection, solution 50 mg/mL Current Limited Availability Manufacturing 2/10/2024 dosulepin (dothiepin) hydrochloride Capsule, hard 25 mg Current Unavailable Manufacturing 2/10/2024 atomoxetine hydrochloride Capsule, hard 45.5 mg Current Unavailable Manufacturing 2/10/2024 fluconazole Capsule, hard 200 mg Anticipated Available Manufacturing 2/10/2024 phenytoin sodium Capsule, hard 100 mg Resolved Available Manufacturing 2/10/2024 lacosamide Tablet, film coated 50 mg Anticipated Available Manufacturing 2/10/2024 risperidone Oral Liquid, solution 1 mg/mL Resolved Available Manufacturing 2/10/2024 teriflunomide Tablet, film coated 14 mg Anticipated Available Manufacturing 2/10/2024 pregabalin Capsule, hard 75 mg Anticipated Available Manufacturing 2/10/2024 pregabalin Capsule, hard 75 mg Anticipated Available Manufacturing 2/10/2024 methylphenidate hydrochloride Tablet, modified release 54 mg Current Unavailable Manufacturing 2/10/2024 captopril Tablet, uncoated 25 mg Resolved Available Manufacturing 2/10/2024 captopril Tablet, uncoated 50 mg Resolved Available Manufacturing 2/10/2024 indapamide hemihydrate Tablet 2.5 mg Resolved Available Manufacturing 2/10/2024 metformin hydrochloride Tablet, film coated 1000 mg Resolved Available Manufacturing 2/10/2024 rasagiline mesilate Tablet 1.56 mg Current Limited Availability Manufacturing 1/10/2024 Rabies virus Injection, powder for 2.5 IU Resolved Available Manufacturing 1/10/2024 prasugrel Tablet, film coated 10 mg Current Limited Availability Manufacturing 1/10/2024 spironolactone Tablet, uncoated 100 mg Resolved Available Manufacturing 1/10/2024 sugammadex sodium Injection, solution 217.6 mg Resolved Available Commercial Changes / Commercial viability 1/10/2024 Follitropin beta Injection, solution 833 IU/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 1/10/2024 clonidine hydrochloride Tablet, uncoated 150 microgram Current Limited Availability Manufacturing 1/10/2024 Peginterferon alfa2a Injection, solution 135 microgram Anticipated Available Unexpected increase in consumer demand 1/10/2024 Peginterferon alfa2a Injection, solution 180 microgram Anticipated Available Unexpected increase in consumer demand 1/10/2024 pimecrolimus Cream 10 mg/g Current Limited Availability Manufacturing 1/10/2024 griseofulvin Tablet, uncoated 125 mg Current Unavailable Manufacturing 30/09/2024 sodium pyrophosphate Injection, powder for 30 mg Current Limited Availability Manufacturing 30/09/2024 hydrocortisone sodium succinate Injection, powder for 134 mg Resolved Available Manufacturing 30/09/2024 cefepime hydrochloride monohydrate Injection, powder for 1189.2 mg Anticipated Available Manufacturing 30/09/2024 lacosamide Tablet, film coated 100 mg Current Limited Availability Commercial Changes / Commercial viability 30/09/2024 lacosamide Tablet, film coated 150 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 30/09/2024 heparin sodium Injection, solution 5000 IU/mL Current Limited Availability Manufacturing 30/09/2024
ドイツ
- 2024.10.29
Active ingredients Date of the last message Type of reason Message type Salbutamol sulfate 25.10.2024 Other Initial notification Samarium-((153)Sm)-Lexidronam pentasodium 25.10.2024 Production problem Initial notification Tobramycin 25.10.2024 Other Change notification Betamethasone 25.10.2024 Other Initial notification Metoprolol succinate (Ph.Eur.) 25.10.2024 Other Change notification Phenoxymethylpenicillin potassium 25.10.2024 Other Change notification Ciprofloxacin hydrochloride (1:1) 1 H<2>O 25.10.2024 Other Change notification Amoxicillin trihydrate 25.10.2024 Other Change notification Fluticasone propionate (Ph.Eur.) 25.10.2024 Other Initial notification Cefaclor monohydrate 24.10.2024 Other Change notification Clarithromycin 24.10.2024 Other Change notification Phenoxymethylpenicillin potassium 24.10.2024 Other Change notification Oxcarbazepine 24.10.2024 Other Change notification Paricalcitol 24.10.2024 Other Change notification Tacrolimus monohydrate 24.10.2024 Other Change notification Doxycycline hyclate 24.10.2024 Other Change notification Amoxicillin trihydrate 24.10.2024 Other Change notification Phenoxymethylpenicillin potassium 24.10.2024 Other Change notification Sodium (methylprednisolone-21-succinate) 23.10.2024 Other Initial notification Clonazepam 23.10.2024 Other Initial notification Levetiracetam 23.10.2024 Other Change notification Ciprofloxacin lactate 23.10.2024 Other Change notification Timolol maleate 23.10.2024 Production problem Change notification Proxymetacaine hydrochloride 23.10.2024 Production problem Change notification Atropine sulphate (Ph.Eur.) 23.10.2024 Production problem Change notification Fluorometholone 23.10.2024 Production problem Change notification ofloxacin 23.10.2024 Production problem Change notification Hydrocortisone acetate (Ph.Eur.) 23.10.2024 Production problem Change notification Dexamethasone; gentamicin sulphate 23.10.2024 Production problem Change notification Anidulafungin 22.10.2024 Production problem Initial notification Sodium((99)Mo)molybdate; sodium((99m)Tc)pertechnetate 22.10.2024 Production problem Initial notification Buprenorphine 22.10.2024 Other Change notification Hydromorphone hydrochloride 22.10.2024 Other Change notification Buprenorphine 22.10.2024 Other Change notification [(186)Re]Rhenium sulfide o.w.A. 21.10.2024 Production problem Initial notification ((169)Er)Erbium citrate 21.10.2024 Production problem Initial notification ((90)Y)Yttrium citrate 21.10.2024 Production problem Initial notification Morphine sulphate (Ph.Eur.) 21.10.2024 Production problem Change notification Buprenorphine hydrochloride 21.10.2024 Production problem Initial notification Olanzapine embonate monohydrate 21.10.2024 Production problem Change notification Hydrocortisone 21.10.2024 Other Initial notification Fluorouracil 21.10.2024 Other Change notification Flunisolide hemihydrate 21.10.2024 Other Initial notification Tobramycin 21.10.2024 Other Change notification - 2024.10.23
Active ingredients Message type Type of reason Date of the last message Venlafaxine hydrochloride Change notification Production problem 18.10.2024 Venlafaxine hydrochloride Initial notification Production problem 18.10.2024 Venlafaxine hydrochloride Initial notification Production problem 18.10.2024 Levetiracetam Change notification Other 18.10.2024 Hydromorphone hydrochloride Change notification Other 18.10.2024 Linezolid Initial notification Other 17.10.2024 Ciclosporin Initial notification Other 17.10.2024 Azithromycin dihydrate Change notification Other 17.10.2024 Azithromycin dihydrate Change notification Other 17.10.2024 Amoxicillin trihydrate Initial notification Other 17.10.2024 Amoxicillin trihydrate; potassium clavulanate Initial notification Other 17.10.2024 Everolimus Initial notification Other 16.10.2024 Oxcarbazepine Initial notification Other 16.10.2024 Urea; tretinoin Change notification Other 16.10.2024 Azithromycin monohydrate Change notification Other 16.10.2024 Phenoxymethylpenicillin potassium Change notification Other 16.10.2024 Phenobarbital Change notification Other 16.10.2024 Haloperidol Initial notification Other 16.10.2024 Ethosuximide Change notification Other 16.10.2024 Amoxicillin trihydrate Change notification Other 16.10.2024 Minocycline hydrochloride ((anhydrous, not pharmacopoeia compliant)) Change notification Other 16.10.2024 Solifenacin succinate Initial notification Production problem 15.10.2024 Eletriptan hydrobromide Change notification Other 15.10.2024 Levetiracetam Change notification Production problem 14.10.2024 Insulin aspart Change notification Other 14.10.2024 Insulin aspart Change notification Other 14.10.2024 Remifentanil hydrochloride Change notification Other 14.10.2024 Oxycodone hydrochloride (Ph.Eur.) Initial notification Other 14.10.2024 Pramipexole dihydrochloride monohydrate Initial notification Other 14.10.2024 Pramipexole dihydrochloride monohydrate Change notification Other 14.10.2024 Pramipexole dihydrochloride monohydrate Change notification Other 14.10.2024 Etoricoxib Initial notification Other 14.10.2024 Eletriptan hydrobromide Initial notification Other 14.10.2024 Oxycodone hydrochloride (Ph.Eur.) Change notification Other 14.10.2024 Topiramate Change notification Other 14.10.2024 Lanthanum(III) carbonate x H<2>O Initial notification Other 14.10.2024 Omeprazole Change notification Other 14.10.2024 Phenytoin Initial notification Other 14.10.2024 Ciprofloxacin hydrochloride (1:1) 1 H<2>O Change notification Other 14.10.2024 Paricalcitol Change notification Other 14.10.2024 Oxcarbazepine Change notification Other 14.10.2024 Phenoxymethylpenicillin potassium Change notification Other 14.10.2024 Phenoxymethylpenicillin potassium Change notification Other 14.10.2024 Phenoxymethylpenicillin benzathine Initial notification Other 14.10.2024 Itraconazole Change notification Other 14.10.2024 Hydromorphone hydrochloride Change notification Other 14.10.2024 Urapidil Change notification Other 11.10.2024 Amoxicillin trihydrate Change notification Other 11.10.2024 Hydrochlorothiazide; metoprolol tartrate (Ph.Eur.) Change notification Other 11.10.2024 Sodium hydrogen carbonate Change notification Other 11.10.2024 Methylphenidate hydrochloride Change notification Other 11.10.2024 Methylphenidate hydrochloride Change notification Other 11.10.2024 Methylphenidate hydrochloride Change notification Other 11.10.2024 Methylphenidate hydrochloride Change notification Other 11.10.2024 Turoctocog alfa Initial notification Other 10.10.2024 Eptacog alfa (activated) Initial notification Other 10.10.2024 Phenprocoumon Change notification Production problem 10.10.2024 Estradiol hemihydrate Initial notification Production problem 10.10.2024 Tenofovir disoproxil Change notification Other 10.10.2024 Rasagiline mesilate Change notification Production problem 10.10.2024 Salbutamol sulfate Change notification Other 10.10.2024 Amoxicillin trihydrate Change notification Other 10.10.2024 Ciprofloxacin hydrochloride (1:1) 1 H<2>O Change notification Other 10.10.2024 Metoprolol tartrate (Ph.Eur.) Change notification Other 10.10.2024 - 2024.10.10
有効成分 投与形態 理由 メッセージの種類 最後のメッセージの日付 オランザピンエンボン酸一水和物 Erhte 需要 変更通知 09.10.2024 オランザピンエンボン酸一水和物 パウダー メーカー変更 変更通知 09.10.2024 インスリンアスパルト Injektionslung その他 変更通知 09.10.2024 ベタメタゾン酢酸エステル（Ph.Eur.）；ベタメタゾンリン酸二水素二ナトリウム（Ph.Eur.） インジェクション・サスペンション 生産能力不足 最初の通知 09.10.2024 アジスロマイシン一水和物 フィルムコート錠 Erhte 需要 変更通知 09.10.2024 コレカルシフェロール 経口ドロップ 生産能力不足 最初の通知 09.10.2024 クエン酸スフェンタニル Injektionslung 生産における問題 最初の通知 08.10.2024 エゼチミブ タブレット Erhte 需要 変更通知 08.10.2024 エプタコグ アルファ（活性化） パウダー 生産能力不足 最初の通知 08.10.2024 アモキシシリン三水和物 経口懸濁液調製用粉末 Erhte 需要 変更通知 08.10.2024 セマグルチド Injektionslung Erhte 需要 変更通知 08.10.2024 フマル酸クエチアピン（欧州製薬） 徐放錠 生産における問題 最初の通知 07.10.2024 オメプラゾール 腸溶性コーティング・ハードカプセル Erhte 需要 変更通知 07.10.2024 トブラマイシン 注射用Lung Erhte 需要 最初の通知 07.10.2024 フェノキシメチルペニシリンカリウム 経口用 Lung 調製用粉末 Erhte 需要 変更通知 07.10.2024 フマル酸クエチアピン（欧州製薬） 徐放錠 生産における問題 変更通知 07.10.2024 アトモキセチン塩酸塩 ハードカプセル 生産における問題 変更通知 07.10.2024 リザトリプタン安息香酸塩 タブレット 生産における問題 変更通知 07.10.2024 リザトリプタン安息香酸塩 溶解タブレット 生産における問題 変更通知 07.10.2024 リザトリプタン安息香酸塩 タブレット 生産における問題 変更通知 07.10.2024 リネゾリド フィルムコート錠 Erhte 需要 変更通知 07.10.2024 エゼチミブ タブレット Erhte 需要 変更通知 07.10.2024 エゼチミブ; シンバスタチン タブレット バッチテストの問題点 変更通知 07.10.2024 ヒドロモルフォン塩酸塩 ハードカプセル 生産能力不足 最初の通知 07.10.2024 塩酸ベナゼプリル 変更通知 07.10.2024 <2>シトロネン舫-レ-ビスマス-カリウム塩（2：1：5）×H O; メトロニダゾール; 塩酸テトラサイクリン ハードカプセル Erhte 需要 変更通知 04.10.2024 塩酸レミフェンタニル 粉末・・・注射剤/輸液用濃縮液ung Erhte 需要 変更通知 04.10.2024 トラゾドン塩酸塩 タブレット 生産能力不足 変更通知 04.10.2024 フェノキシメチルペニシリンカリウム フィルムコート錠 その他 変更通知 04.10.2024 オクスカルバゼピン 経口懸濁液 その他 変更通知 04.10.2024 クラリスロマイシン 経口懸濁液調製用顆粒 Erhte 需要 変更通知 04.10.2024 アジスロマイシン二水和物 経口懸濁液調製用粉末 Erhte 需要 変更通知 04.10.2024 ラモトリギン タブレット 生産能力不足 変更通知 04.10.2024 パリカルシトール Injektionslung Erhte 需要 変更通知 04.10.2024 ジヒドロコデイン［（R 変更通知 03.10.2024 ウロキナーゼ 注射剤/輸液用粉末ung Erhte 需要 変更通知 02.10.2024 オランザピンエンボン酸一水和物 パウダー メーカー変更 最初の通知 02.10.2024 エトスクシミド ソフトカプセル Erhte 需要 変更通知 02.10.2024 硫酸フラマイセチン(1:x) ((硫黄含有量の詳細)) 肌に塗布するパウダー 生産能力不足 変更通知 02.10.2024 フシジン（Ph.Eur.） クリーム 生産能力不足 変更通知 02.10.2024 ドキシサイクリン一水和物 タブレット 生産能力不足 最初の通知 02.10.2024 モメタゾンフロエート（Ph.Eur.） L、皮膚に塗布する。 生産能力不足 変更通知 01.10.2024 プレドニカルベート L、皮膚に塗布する。 生産能力不足 最初の通知 01.10.2024 タクロリムス一水和物 軟膏 Erhte 需要 変更通知 01.10.2024 ヒドロモルフォン塩酸塩 徐放錠 Erhte 需要 変更通知 01.10.2024 酢酸プレドニゾロン 点眼液懸濁液 生産における問題 変更通知 01.10.2024 カスポファンギンジアセテート 01.10.2024 最初の通知 01.10.2024 アトモキセチン塩酸塩 ハードカプセル 生産における問題 変更通知 01.10.2024 アトモキセチン塩酸塩 ハードカプセル 生産における問題 変更通知 01.10.2024 クラリスロマイシン 経口懸濁液調製用顆粒 Erhte 需要 変更通知 30.09.2024 塩酸バンコマイシン ハードカプセル Erhte 需要 変更通知 30.09.2024 塩酸シナカルセス フィルムコート錠 生産における問題 最初の通知 30.09.2024 ヒドロモルフォン塩酸塩 徐放錠 生産における問題 変更通知 30.09.2024 ニクロサミド チュアブル錠 その他 最初の通知 30.09.2024 塩酸レミフェンタニル 粉末・・・注射剤/輸液用濃縮液ung Erhte 需要 変更通知 27.09.2024 アモキシシリン三水和物 経口懸濁液調製用粉末 Erhte 需要 変更通知 27.09.2024 エプタコグ アルファ（活性化） パウダー 生産能力不足 最初の通知 27.09.2024 硫酸ビンクリスチン Injektionslung 生産における問題 最初の通知 27.09.2024 アトモキセチン塩酸塩 ハードカプセル 生産における問題 変更通知 26.09.2024 メトロニダゾール タブレット 生産における問題 変更通知 26.09.2024 クラリスロマイシン フィルムコート錠 生産能力不足 最初の通知 26.09.2024 ノナコグ・ベータ・ペゴル パウダー 生産能力不足 最初の通知 26.09.2024 塩酸シナカルセス その他 変更通知 25.09.2024 リスペリドン デポー注射用懸濁液調製用粉末 Erhte 需要 最初の通知 25.09.2024 チモロールマレイン酸塩 目薬 生産における問題 変更通知 25.09.2024 クロモグリク酸ナトリウム（Ph.Eur.）；塩酸レプロテロール 生産における問題 変更通知 25.09.2024 タクロリムス一水和物 生産における問題 変更通知 25.09.2024 塩酸メチルフェニデート タブレット その他 変更通知 24.09.2024 フェノキシメチルペニシリンカリウム タブレット Erhte 需要 最初の通知 24.09.2024 ドキシサイクリン塩酸塩 タブレット Erhte 需要 最初の通知 24.09.2024 <2>シプロフロキサシン塩酸塩（1：1） 1 H O フィルムコート錠 Erhte 需要 変更通知 23.09.2024 硫酸サルブタモール Lung f・ネブライザー 生産能力不足 最初の通知 23.09.2024 ラモトリギン タブレット 生産における問題 最初の通知 23.09.2024 レベチラセタム フィルムコート錠 生産における問題 変更通知 23.09.2024
フランス
- 2024.10.29
Status Update Specialty Supply tension Oct. 25, 2024 Cynomel 0.025 mg, scored tablet- [liothyronine sodium] Supply tension Oct. 25, 2024 Ultratechnekow FM, 2.15 – 43 GBq, radiopharmaceutical generator – [sodium (molybdate (VI) [99 Mo] de) Supply voltage Oct. 25, 2024 Tekcis 2-50 GBq, radiopharmaceutical generator – [sodium (molybdate (VI) [99 Mo] de) Marketing discontinued Oct. 25, 2024 Heparin Choay 25 000 IU/5 ml, solution for injection, 1 glass vial(s) of 5 ml – [heparin sodium]. Marketing discontinuation Oct. 24, 2024 Tsoludose, oral solution in unidose container – [levothyroxine] Supply tension 24-Oct-24 Clarithromycin 25 mg/ml and 50 mg/ml, granules for oral suspension – [clarithromycin] Supply tension Oct. 24, 2024 Clarithromycin, 250 and 500 mg, modified-release film-coated tablet and film-coated tablet – [clarithromycin] Supply tension Oct. 23, 2024 Amikacine Viatris 250 mg, 500 mg and 1g, powder for injectable solution in vial – [amikacine (sulfate d’) Availability Oct. 23, 2024 Hospira sodium pamidronate 9 mg/ml, dilutable solution for infusion – [sodium (pamidronate de)] Availability Oct. 23, 2024 Ultiva 1 mg, powder for solution for injection or infusion – [remifentanil (hydrochloride)] Supply tension Oct. 22, 2024 Zypadhera 210, 300, 405 mg, powder and solvent for prolonged-release suspension for injection – [olanzapine (pamoate) monohydrate]. Supply tension Oct. 22, 2024 Pegasys 90 micrograms, 135 micrograms and 180 micrograms solution for injection in pre-filled syringes – [peginterferon alfa-2a] [peginterferon alfa-2a] [peginterferon alfa-2a] [peginterferon alfa-2a Out of stock Oct. 21, 2024 Icatibant Viatris 30 mg, solution for injection in pre-filled syringe – [icatibant (acetate) Supply tension Oct. 21, 2024 Hexatrione 2 per cent, suspension for injection (intra-articular) – [Triamcinolone Hexacetonide]. - 2024.10.23
Status Update Specialty Out of stock Oct. 18, 2024 Cyanokit 5 g, powder for solution for infusion – [hydroxocobalamin] Supply voltage Oct. 18, 2024 Isocard, sublingual solution in spray bottle – [isosorbide dinitrate] Supply tension Oct. 18, 2024 Paliperidone Teva, prolonged-release suspension for injection – [paliperidone] Supply tension Oct. 17, 2024 Levodopa Carbidopa Teva 100 mg/10 mg, scored tablet – [levodopa – carbidopa] Supply tension Oct. 17, 2024 Levodopa Carbidopa Teva 250 mg/25 mg, scored tablet – [levodopa – carbidopa] Out of stock Oct. 17, 2024 NovoEight 3000 IU powder and solvent for solution for injection – [turoctocog alfa] [turoctocog alfa] [turoctocog alfa] [turoctocog alfa Availability Oct. 16, 2024 Solumedrol 120 mg/2 ml, lyophilisate and solution for parenteral use – [methylprednisolone (hydrogen succinate)] Supply tension Oct. 16, 2024 Atropine 1%, eye drops – [atropine (sulfate) Availability Oct. 16, 2024 Tofranil 25 mg, coated tablet – [Imipramine] Out of stock Oct. 16, 2024 Zophren 2 mg/ml, solution for injection in ampoule (IV), (box 1 ampoule of 4 ml) – [ondansetron]. Remise à disposition Oct. 16, 2024 Irinotecan Sun 1.5 mg/ml, solution for infusion – [irinotecan (hydrochloride) trihydrate] Availability Oct. 15, 2024 Solumedrol 40 mg/1 mL, powder and solvent for solution for injection – [methylprednisolone hemisuccinate] Supply tension Oct. 15, 2024 Ondansetron Viatris 2 mg/ml, solution for injection (I.V.) – [ondansetron] Supply tension Oct. 14, 2024 Fluorescein Faure 0.5%, eye drops solution in single-dose container – [fluorescein sodium]. Availability Oct. 11, 2024 Nozinan 100 mg, scored film-coated tablet – [levomepromazine (maleate)] Supply tension Oct. 11, 2024 Noyada 25 mg/5 ml, oral solution – [captopril] Out of stock Oct. 11, 2024 Yellox 0.9 mg/ml, eye drops solution – [bromfenac sodium sesquihydrate]. Supply tension Oct. 11, 2024 Praluent 75 mg, 150 mg and 300 mg, solution for injection in pre-filled pen – [alirocumab (mammalian/hamster/ cho cells)]. Availability Oct. 10, 2024 NovoEight 2000 IU powder and solvent for injectable solution – [turoctocog alfa] - 2024.10.10
ステータス (英語) アップデート スペシャルティ 回復 2024年10月9日 トリフルカン 40mg/ml、経口懸濁用粉末 – [フルコナゾール］ 回復 2024年10月9日 フレカイニド100mg、点滴静注用 – [フレカイニド（酢酸塩］ 回復 2024年10月9日 ノボセブン8mg（400KUI）、注射用粉末および溶液用溶剤-［エプタコグ アルファ（活性化）-（哺乳類／ハムスター／BHK細胞）］について 在庫切れ 2024年10月7日 トキシカーブ 飲む懸濁液 【活性炭 在庫切れ 2024年10月7日 メトトレキサート・アコード 100mg/mL、輸液用希釈液 – [メトトレキサート］ 供給の緊張 2024年10月4日 アトロピン1%点眼液 – [アトロピン（硫酸塩） 回復 2024年10月4日 コアガデックス500IU、注射用溶液の粉末および溶媒 – ［ヒト凝固第X因子］ 在庫切れ 2024年10月3日 パクリタキセルAHCL 6 mg/ml、輸液用希釈液 – 100 ml バイアル – [パクリタキセル］ 供給の緊張 2024年10月3日 トランキセン 20mg/2mL、凍結乾燥品および非経口用溶液 – [クロラゼプ酸ジカリウム］ 在庫切れ 2024年10月3日 エトポシド・アコード 20mg/ml、輸液用希釈液 – [エトポシド］ 供給の緊張 2024年10月3日 トルリシティ 0.75mg、1.5mg、3mg、4.5mg、プレフィルドペン注射液 – [デュラグルチド］ 供給の緊張 2024年10月2日 トランドラプリル0.5mg、カプセル – [trandolapril］ 供給の緊張 2024年10月2日 パリペリドン・テバ、注射用徐放性懸濁液 – [パリペリドン］ 供給の緊張 2024年10月2日 免疫グロブリン点滴静注用・静注用（ベース）-［免疫グロブリン点滴静注用（IgG）］。 供給の緊張 2024年10月1日 タイエン162mg、プレフィルドペンおよびプレフィルドシリンジ入り注射液 – [トシリズマブ］ 回復 2024年10月1日 ジナート125mg/5ml小児・乳児用、経口懸濁用顆粒80ml入りボトル – [セフロキシム・アキセチル］ 供給の緊張 2024年10月1日 ロピニロールLP 2mg、4mg、8mg フィルムコーティング錠 – [ロピニロール（塩酸塩） 供給の緊張 2024年9月30日 リネゾリド 2mg/ml、輸液用 – 【リネゾリド 在庫切れ 2024年9月30日 トランドラプリル2mg、4mg – [trandolapril］
英国
- 2024.10.30
Support for medicines shortages
Managing the shortage of Molybdenum-99 / Technetium-99m generators (Published 25 October 2024)Supplies are limited till mid-November 2024. Actions and guidance are as provided in National Patient Safety Alert (NatPSA/2024/012/DHSC) issued on 25th October.
- 2024.10.23
医薬品供給通知:NovoRapid®(インスリンアスパルト)FlexTouch® 100ユニット/ ml注射用溶液3mlプレフィルドペン
NovoRapid FlexTouchの在庫は、2025年3月までに枯渇すると予想されます。NovoRapid® FlexPen®とPenfill® 100 units/mlは引き続き利用可能で、インスリンアスパルトバイオシミラー、TrurapiプレフィルドSoloStarペン、3mlカートリッジと同様に、需要の増加に完全に対応できます。
出典:Community Pharmacy England
EU
EUの情報はありません。